Does receptor-'C(k)' deficiency initiate leukaemia?

Cancer Letters

Volumn 112, Issue 2, 1997, Pages 199-202

  Kaul, D ^a   Singh, Jarnail ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Brain tumor; Hepatic cell line; Human organs cells; Leukaemic cells patients; Receptor 'C(k)'

Indexed keywords

CELL SURFACE RECEPTOR; MEVALONIC ACID; POLYCLONAL ANTIBODY; PROTEIN; ANTIBODY; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN TYROSINE KINASE;

ADRENAL CORTEX; AORTA; ARTICLE; BRAIN; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL SURFACE; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEUKEMIA CELL; LEUKEMOGENESIS; LIVER; LYMPHOCYTE; PRIORITY JOURNAL; ANTIBODY SPECIFICITY; BRAIN TUMOR; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; FEMALE; GLIOBLASTOMA; IMMUNOLOGY; OVARY TUMOR; ULTRASTRUCTURE; WESTERN BLOTTING;

ANTIBODIES; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LIVER; OVARIAN NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, LDL; TUMOR CELLS, CULTURED;

EID: 0031590882     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04570-3     Document Type: Article

References (15)

1. [1] Goldstein, J.L. and Brown, M.S. (1990) Regulation of mevalonate pathway, Nature, 343, 425-429.
2. [2] Siperstein, M.D. (1984) Role of cholesterogenesis and isoprenoid synthesis in DNA replication and cell growth, J. Lipid Res., 25, 1462-1468.
3. [3] Vitols, S., Gahrton, G., Ost, A. and Peterson, C. (1984) Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation, Blood, 63, 1186-1193.
4. [4] Siperstein, M.D. (1970) Regulation of cholesterol biosynthesis in normal and malignant tissues, Curr. Top. Cell Regul., 2, 65-100.
5. [5] Polsky, F.I., Brown, M.S. and Siperstein, M.D. (1973) Feedback control of cholesterol synthesis in circulating granulocytes and deletion of feedback control in granulocytic leukemia, J. Clin. Invest., 52, 65a.
6. [6] Inbar, M. and Shinitzky, M. (1974) Cholesterol as a bioregulator in the development and inhibition of leukemia, Proc. Natl. Acad. Sci. USA, 71, 4229-4231.
7. [7] Muller, C.P., Wagner, A.U., Maucher, C. and Steinke, B. (1989) Hypocholesterolemia, an unfavourable feature of prognostic value in chronic myeloid leukemia, Curr. J. Haematol., 43, 235-239.
8. [8] Kaul, D. (1993) Do human platelets possess LDL receptor specific for apoprotein 'B' or cholesterol?, Curr. Sci., 65, 883-886.
9. [9] Kaul, D. and Singh, J. (1994) Exogenous cholesterol initiated transmembrane signalling pathway regulates cholesterogenesis in human platelets, Cell. Signalling, 6, 141-145.
10. k' dependent signalling in human platelets, Mol. Cell. Biochem., 151, 173-176.
11. [11] Kaul, D., Dhawan, V. and Kaur, M. (1996) Evidence and nature of a novel thiol-oxidase in human platelets. Mol. Cell. Biochem., in press.
12. [12] Marlow, E. and Lane, D. (1988) Storing and purifying antibodies. In: Antibodies: a Laboratory Manual, pp. 283-318. Editors: E. Harlow and D. Lane. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
13. [13] Barbu, V. and Dautry, F. (1990) Mevalonate deprivation alters the induction of fos and myc by growth factors, Oncogene, 7, 107-108.
14. [14] Nitta, M., Kato, Y., et al. (1985) Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood, 66, 1053-1061.
15. [15] Bocckino, S.B., Wilson, P.B. and Exton, J.H. (1991) Phosphatidate-dependent protein phosphorylation. Proc. Natl. Acad. Sci. USA, 88, 6210-6213.